Fig. 3From: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKaplan–Meier curves for progression-free survival (PFS) and overall survival (OS). A PFS and B OS in uncommon non-small cell lung cancer (uNSCLC, solid line) and propensity-score-matched common NSCLC (cNSCLC, dashed line)Back to article page